These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27415034)

  • 1. Perspectives on investigational drugs and immunotherapies for glioblastoma.
    Miller JJ; Curry WT; Cahill DP; Dietrich J
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1007-9. PubMed ID: 27415034
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
    Reardon DA; Mitchell DA
    Semin Immunopathol; 2017 Feb; 39(2):225-239. PubMed ID: 28138787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivosidenib, an IDH1 inhibitor, in a patient with recurrent,
    Tejera D; Kushnirsky M; Gultekin SH; Lu M; Steelman L; de la Fuente MI
    CNS Oncol; 2020 Sep; 9(3):CNS62. PubMed ID: 32716208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological challenges for peptide-based immunotherapy in glioblastoma.
    Mohme M; Neidert MC; Regli L; Weller M; Martin R
    Cancer Treat Rev; 2014 Mar; 40(2):248-58. PubMed ID: 24064197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory Nanomedicine.
    Bartneck M
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28383783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.
    Maxwell R; Jackson CM; Lim M
    Curr Treat Options Oncol; 2017 Aug; 18(8):51. PubMed ID: 28785997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
    Khansur E; Shah AH; Lacy K; Komotar RJ
    Cancer Invest; 2019; 37(1):1-7. PubMed ID: 30632816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for secondary glioblastoma multiforme: toward an isocitrate dehydrogenase vaccine.
    Abecassis IJ; Morton RP; Nerva JD; Kim LJ
    World Neurosurg; 2014 Dec; 82(6):933-5. PubMed ID: 25311977
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunotherapy in brain tumors].
    De Carli E; Delion M; Rousseau A
    Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects of biological and synthetic pharmacotherapies for glioblastoma.
    Altshuler DB; Kadiyala P; Nuñez FJ; Nuñez FM; Carney S; Alghamri MS; Garcia-Fabiani MB; Asad AS; Nicola Candia AJ; Candolfi M; Lahann J; Moon JJ; Schwendeman A; Lowenstein PR; Castro MG
    Expert Opin Biol Ther; 2020 Mar; 20(3):305-317. PubMed ID: 31959027
    [No Abstract]   [Full Text] [Related]  

  • 11. Methods of resistance to epidermal growth factor receptor inhibition in glioblastoma multiforme.
    Komotar RJ; Starke RM; Connolly ES; Sisti MB
    Neurosurgery; 2012 Feb; 70(2):N13-4. PubMed ID: 22251981
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccine strategies for glioblastoma: progress and future directions.
    Jackson C; Ruzevick J; Brem H; Lim M
    Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for cancer: focusing on developing treatments rather than drugs.
    Sznol M
    Curr Opin Investig Drugs; 2001 Jul; 2(7):957-8. PubMed ID: 11757798
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in Immunotherapy for Glioblastoma Multiforme.
    Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X
    J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upcoming innovations in lung cancer immunotherapy: focus on immune checkpoint inhibitors.
    Aspeslagh S; Marabelle A; Soria JC; Armand JP
    Chin Clin Oncol; 2015 Dec; 4(4):48. PubMed ID: 26730760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TG-4010 Transgene.
    Cohen S; Kaufman HL
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1319-28. PubMed ID: 15648954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular-based immunotherapies for patients with glioblastoma multiforme.
    Xu X; Stockhammer F; Schmitt M
    Clin Dev Immunol; 2012; 2012():764213. PubMed ID: 22474481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials. Experimental cancer therapies move to the front line.
    Couzin-Frankel J
    Science; 2012 Jan; 335(6066):282-3. PubMed ID: 22267789
    [No Abstract]   [Full Text] [Related]  

  • 19. Dendritic cell vaccines to combat glioblastoma.
    Wheeler CJ
    Expert Rev Neurother; 2010 Apr; 10(4):483-6. PubMed ID: 20367199
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy for glioblastoma: are we finally getting closer?
    Lim M
    Neuro Oncol; 2015 Jun; 17(6):771-2. PubMed ID: 25964313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.